The choice between Jardiance vs Ozempic for weight loss depends on individual health needs, preferences, and response to treatment as guided by healthcare professionals
The Phase 3 programme , understood to be known as the TRIUMPH trials, is now underway and is evaluating retatrutide across broader and more diverse patient populations, including individuals with: Obesity without type 2 diabetes Obesity with type 2 diabetes Obesity-related cardiovascular disease Metabolic dysfunction-associated steatohepatitis (MASH) Readers seeking the most current information on trial status, registered populations, and endpoints are encouraged to consult ClinicalTrials.gov directly, where Phase 3 trial registrations for retatrutide can be found
Patients with a broader interest in longevity may also want to review Longevity Care at Tucson Wellness MD
Guo A, Li K, Tian HC, et al
doi: 10.1111/dom.13172 123 UK Prospective Diabetes Study Group